Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linperlisib + CHOP and Auto-HSCT in nTFHL
NCT06347653Phase 2Recruiting
- Sponsor
- Peking University
- Start
- Nov 2023
- Primary completion
- Jan 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of linperlisib in follicular T-cell lymphoma (FTCL), sponsored by Peking University. Started Nov 2023; status: recruiting.
02
Drugs
linperlisib
03
Conditions
follicular T-cell lymphoma (FTCL)
Beyond the preview
Go deeper on NCT06347653.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06347653.